A Comparison of Indocyanine Green Fluorescence Imaging Plus Blue Dye and Blue Dye Alone for Sentinel Node Navigation Surgery in Breast Cancer Patients

[1] Krag DN(1988)The sentinel node in breast cancer—a multicenter validation study N Engl J Med. 339 941-946

[2] Weaver D(2007)Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol. 18 1133-1144

[3] Ashikaga T(2010)Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol. 11 927-933

[4] Goldhirsch A(1998)Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer Ann Surg. 227 645-653

[5] Wood WC(2005)Guidelines to assure quality in breast cancer surgery Eur J Surg Oncol. 31 568-576

[6] Galber RD(2003)How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg. 185 202-210

[7] Krag DN(2005)Modifications of the learning curve guidelines for breast cancer sentinel node biopsy Eur J Surg Oncol. 31 357-363

[8] Anderson SJ(2005)Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer Breast Cancer. 12 211-215

[9] Julian TB(2008)Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer Am J Surg. 195 850-853

[10] Cox CE(2001)Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study Ann Surg. 233 676-687

[1] Krag DN(1988)The sentinel node in breast cancer—a multicenter validation study N Engl J Med. 339 941-946

[2] Weaver D(2007)Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol. 18 1133-1144

[3] Ashikaga T(2010)Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol. 11 927-933

[4] Goldhirsch A(1998)Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer Ann Surg. 227 645-653

[5] Wood WC(2005)Guidelines to assure quality in breast cancer surgery Eur J Surg Oncol. 31 568-576

[6] Galber RD(2003)How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg. 185 202-210

[7] Krag DN(2005)Modifications of the learning curve guidelines for breast cancer sentinel node biopsy Eur J Surg Oncol. 31 357-363

[8] Anderson SJ(2005)Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer Breast Cancer. 12 211-215

[9] Julian TB(2008)Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer Am J Surg. 195 850-853

[10] Cox CE(2001)Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study Ann Surg. 233 676-687